BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17035385)

  • 1. Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers.
    Hecht SS; Carmella SG; Yoder A; Chen M; Li ZZ; Le C; Dayton R; Jensen J; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1805-11. PubMed ID: 17035385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of phenanthrols in human urine by gas chromatography-mass spectrometry: potential use in carcinogen metabolite phenotyping.
    Carmella SG; Chen M; Yagi H; Jerina DM; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2167-74. PubMed ID: 15598776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of urinary phenanthrene metabolite ratios: effect of smoking on the diol epoxide pathway.
    Hecht SS; Chen M; Yoder A; Jensen J; Hatsukami D; Le C; Carmella SG
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2969-74. PubMed ID: 16365018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in human urine: a potential biomarker for assessing polycyclic aromatic hydrocarbon metabolic activation.
    Hecht SS; Chen M; Yagi H; Jerina DM; Carmella SG
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1501-8. PubMed ID: 14693744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenanthrene metabolism in smokers: use of a two-step diagnostic plot approach to identify subjects with extensive metabolic activation.
    Wang J; Zhong Y; Carmella SG; Hochalter JB; Rauch D; Oliver A; Jensen J; Hatsukami DK; Upadhyaya P; Hecht SS; Zimmerman CL
    J Pharmacol Exp Ther; 2012 Sep; 342(3):750-60. PubMed ID: 22674470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race.
    Nock NL; Tang D; Rundle A; Neslund-Dudas C; Savera AT; Bock CH; Monaghan KG; Koprowski A; Mitrache N; Yang JJ; Rybicki BA
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1236-45. PubMed ID: 17548691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A urinary metabolite of phenanthrene as a biomarker of polycyclic aromatic hydrocarbon metabolic activation in workers exposed to residual oil fly ash.
    Kim JY; Hecht SS; Mukherjee S; Carmella SG; Rodrigues EG; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):687-92. PubMed ID: 15767350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
    Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
    Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals.
    Nerurkar PV; Okinaka L; Aoki C; Seifried A; Lum-Jones A; Wilkens LR; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1119-22. PubMed ID: 11045797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of metabolic genotypes on levels of biomarkers of genotoxic exposure.
    Schoket B; Papp G; Lévay K; Mracková G; Kadlubar FF; Vincze I
    Mutat Res; 2001 Oct; 482(1-2):57-69. PubMed ID: 11535249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupational exposure to polycyclic aromatic hydrocarbons in German industries: association between exogenous exposure and urinary metabolites and its modulation by enzyme polymorphisms.
    Rihs HP; Pesch B; Kappler M; Rabstein S; Rossbach B; Angerer J; Scherenberg M; Adams A; Wilhelm M; Seidel A; Brüning T
    Toxicol Lett; 2005 Jul; 157(3):241-55. PubMed ID: 15917149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of [D10]phenanthrene to tetraols in smokers for potential lung cancer susceptibility assessment: comparison of oral and inhalation routes of administration.
    Zhong Y; Wang J; Carmella SG; Hochalter JB; Rauch D; Oliver A; Jensen J; Hatsukami DK; Upadhyaya P; Zimmerman C; Hecht SS
    J Pharmacol Exp Ther; 2011 Jul; 338(1):353-61. PubMed ID: 21515812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
    Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S
    Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells.
    Mollerup S; Ovrebø S; Haugen A
    Int J Cancer; 2001 Apr; 92(1):18-25. PubMed ID: 11279601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
    Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolites of the Polycyclic Aromatic Hydrocarbon Phenanthrene in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.
    Patel YM; Park SL; Carmella SG; Paiano V; Olvera N; Stram DO; Haiman CA; Le Marchand L; Hecht SS
    PLoS One; 2016; 11(6):e0156203. PubMed ID: 27275760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
    Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
    Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate consequences of cigarette smoking: rapid formation of polycyclic aromatic hydrocarbon diol epoxides.
    Zhong Y; Carmella SG; Upadhyaya P; Hochalter JB; Rauch D; Oliver A; Jensen J; Hatsukami D; Wang J; Zimmerman C; Hecht SS
    Chem Res Toxicol; 2011 Feb; 24(2):246-52. PubMed ID: 21184614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
    Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.